
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda
Author(s) -
Rena C Patel,
Randy M Stalter,
Katherine K. Thomas,
Bani Tamraz,
Steven W. Blue,
David W. Erikson,
Christina J. Kim,
Edward J. Kelly,
Kavita Nanda,
Athena P. Kourtis,
Jairam R. Lingappa,
Nelly Mugo,
Jared M. Baeten,
Kimberly K. Scarsi
Publication year - 2019
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002308
Subject(s) - etonogestrel , efavirenz , contraceptive implant , levonorgestrel , nevirapine , norethisterone , progestin , medicine , pharmacokinetics , gynecology , viral load , obstetrics , population , pharmacology , physiology , antiretroviral therapy , family planning , hormone , human immunodeficiency virus (hiv) , immunology , health services , environmental health , research methodology
To evaluate pharmacokinetics and pharmacogenetics of contraceptive implant progestin concentrations in HIV-positive women initiating efavirenz (EFV)-containing or nevirapine (NVP)-containing antiretroviral therapy (ART).